The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator
about
Stiripentol for focal refractory epilepsyAntiepileptic drugs for the treatment of infants with severe myoclonic epilepsyAntiepileptic drugs for the treatment of severe myoclonic epilepsy in infancyStiripentol for focal refractory epilepsyStiripentol for focal refractory epilepsyAntiepileptic drugs for the treatment of severe myoclonic epilepsy in infancyMolecular mechanisms of antiseizure drug activity at GABAA receptorsThe pharmacologic treatment of Dravet syndromeThe Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.A substituted anilino enaminone acts as a novel positive allosteric modulator of GABA(A) receptors in the mouse brain.Editing of neurotransmitter receptor and ion channel RNAs in the nervous systemTherapeutic Drug Monitoring of the Newer Anti-Epilepsy MedicationsStiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).SB-205384 is a positive allosteric modulator of recombinant GABAA receptors containing rat α3, α5, or α6 subunit subtypes coexpressed with β3 and γ2 subunits.The effects of stiripentol on GABA(A) receptorsAllosteric Modulation of GABAA Receptors by an Anilino Enaminone in an Olfactory Center of the Mouse Brain.Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.Pharmacotherapy for Dravet Syndrome.In Silico Prediction of Gamma-Aminobutyric Acid Type-A Receptors Using Novel Machine-Learning-Based SVM and GBDT ApproachesCurrent therapeutic procedures in Dravet syndrome.Na+ channelopathies and epilepsy: recent advances and new perspectives.Stiripentol in Dravet syndrome: results of a retrospective U.S. study.The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters.Pharmacological considerations in the use of stiripentol for the treatment of epilepsy.Stiripentol and vigabatrin current roles in the treatment of epilepsy.Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy.Treatment of Dravet Syndrome.Stiripentol in the Management of Epilepsy.Interactions between modulators of the GABA(A) receptor: Stiripentol and benzodiazepinesRNA editing of the GABA(A) receptor alpha3 subunit alters the functional properties of recombinant receptors.Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels.Commentary: Targeting LDH enzymes with a stiripentol analog to treat epilepsy.Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus.Stiripentol in refractory status epilepticus.Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity.Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain.
P2860
Q24186440-7D8F44B6-8A8C-42DC-AEEB-FA16D5971D96Q24186474-67EC21D3-0EB6-4E92-A22D-0ABA54B0EF94Q24198031-4828C6B3-8BF4-4AA5-8624-3321B849698AQ24198833-CB961F11-AC5E-43FF-8CB5-CF1065257CBEQ24200888-14F3A724-DA28-4759-90E0-F70A17D452A0Q24202411-8B58B545-EADA-4576-9E03-5BCEB617B101Q28681145-4241E756-2EE3-4404-8EBE-A58D4D2D3561Q29013852-24605209-CAB5-4DC0-B3DB-D57010027DA8Q30486732-70C38B5B-1513-46DC-AD54-E578FC1E2CA7Q33646252-3E75A9F2-34AC-4E5B-9EC8-DF98F42D6C46Q33773185-B2192D54-B11D-43E9-BCDB-519F1611E0ACQ33942739-4FA9A7DC-9C62-474A-B8BC-22005B507897Q33996679-4327DF44-2F8C-4253-84C9-0C09FE2D4197Q34302354-A24F601E-F17E-43C2-8829-55694587274CQ34360939-C6187B63-9E73-4A3B-B31F-BC68001EC646Q34660454-2EF01500-683C-462F-8133-642C0E814719Q34774687-C27EF0EB-BAA2-459E-AB69-A1033C6ADE0FQ34941977-5F7C1E4A-E1DD-45A1-AD6A-AB57AC0BB3CFQ35953476-63E0BF9B-6AF4-4D82-846E-5136A5A94B41Q36118214-CC31212A-5C79-48FC-AFF8-9750B849431DQ37866832-045F6631-FA90-4B85-8041-468AA6083128Q37960093-37AE02E9-EF53-4D3D-A78F-5E9662644ECFQ38121171-E7D68AE0-4692-49DF-B816-7FBE2E17BB6EQ38195817-99CBFB84-1F87-4846-AE60-69658DC18DEAQ38738877-ED72656D-2E82-4587-9F52-20FD57FD0D37Q38757727-7DE69896-FB50-4F8D-8512-6C1B2DAA21D3Q38776903-75ED4353-E6BD-4F1A-8657-EA0BC215AA1CQ38855474-F5564F79-364B-4CC5-B128-3D0ADD26DC87Q39256887-17558D05-EE84-4B79-A9B9-A61B2E4E3E97Q39607659-6FF11BD7-2E09-4D88-9548-9FC8E5C4F101Q39860889-159ECBC5-A1CC-478D-9081-122D407587B1Q40382329-DA6CD1CA-909E-4A0B-B424-6DFBAFF80840Q41336182-00D56D4A-BFB2-43DC-8A2B-D3D68FBB13E2Q42077761-839A0471-3413-46B1-8E4D-27950BD9684BQ45758314-EFAC9E6E-4042-4046-A31D-340F1E1C6B4EQ47177872-3812B4E0-1203-4D72-B6A3-53AD31804298Q48940505-69D1ABB3-90E1-44AF-8B74-6E987799C950
P2860
The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The anti-convulsant stiripento ...... positive allosteric modulator
@ast
The anti-convulsant stiripento ...... positive allosteric modulator
@en
The anti-convulsant stiripento ...... positive allosteric modulator
@nl
type
label
The anti-convulsant stiripento ...... positive allosteric modulator
@ast
The anti-convulsant stiripento ...... positive allosteric modulator
@en
The anti-convulsant stiripento ...... positive allosteric modulator
@nl
prefLabel
The anti-convulsant stiripento ...... positive allosteric modulator
@ast
The anti-convulsant stiripento ...... positive allosteric modulator
@en
The anti-convulsant stiripento ...... positive allosteric modulator
@nl
P2860
P3181
P1433
P1476
The anti-convulsant stiripento ...... positive allosteric modulator
@en
P2093
Janet L Fisher
P2860
P3181
P356
10.1016/J.NEUROPHARM.2008.06.004
P407
P577
2009-01-01T00:00:00Z